Bio Law Blog

JUNE 21, 2020

Amgen Inc. and Alexion Pharmaceuticals Inc. settled three Inter Partes Review (IPR) proceedings concerning patents covering Alexion’s blockbuster humanized monoclonal antibody drug Soliris®, with Amgen obtaining a royalty-free license for marketing a biosimilar prior to expiration of the patents at issue. Alexion is the maker of Soliris (eculizumab), a humanized monoclonal antibody against complement protein C5, indicated for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)

Marketing 52

Marketing Marketing Settlement Patent 52

GDB Firm Blog

JUNE 25, 2020

??The "Emergency Rent Relief Act of 2020," signed by Governor Cuomo on June 17, establishes rent relief for residential low-income tenants by providing up to $100,000,000 in voucher payments to landlords to subsidize rent owed by low-income tenants.

40

40

GDB Firm Blog

JUNE 23, 2020

Franchisors and state regulators have been struggling with the issue of how franchisors can continue to sell franchises in the midst of the coronavirus pandemic in a way that is not misleading, particularly if their franchise disclosure document (FDD) contains historical information from 2019 about franchisee financial performance which predates the pandemic?

40

40